Table of Content

1 Myotonic Dystrophy Type 1 (DM1) Market Overview
1.1 Product Overview and Scope of Myotonic Dystrophy Type 1 (DM1)
1.2 Myotonic Dystrophy Type 1 (DM1) Segment by Type
1.2.1 Global Myotonic Dystrophy Type 1 (DM1) Market Value Comparison by Type (2024-2034)
1.2.2 Exondys
1.2.3 Emflaza
1.2.4 Translarna
1.3 Myotonic Dystrophy Type 1 (DM1) Segment by Application
1.3.1 Global Myotonic Dystrophy Type 1 (DM1) Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Myotonic Dystrophy Type 1 (DM1) Market Size Estimates and Forecasts
1.4.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue 2018-2034
1.4.2 Global Myotonic Dystrophy Type 1 (DM1) Sales 2018-2034
1.4.3 Global Myotonic Dystrophy Type 1 (DM1) Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Myotonic Dystrophy Type 1 (DM1) Market Competition by Manufacturers
2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Myotonic Dystrophy Type 1 (DM1) Average Price by Manufacturers (2018-2023)
2.4 Global Myotonic Dystrophy Type 1 (DM1) Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Myotonic Dystrophy Type 1 (DM1), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Myotonic Dystrophy Type 1 (DM1), Product Type & Application
2.7 Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation and Trends
2.7.1 Myotonic Dystrophy Type 1 (DM1) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Myotonic Dystrophy Type 1 (DM1) Players Market Share by Revenue
2.7.3 Global Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Myotonic Dystrophy Type 1 (DM1) Retrospective Market Scenario by Region
3.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Myotonic Dystrophy Type 1 (DM1) Global Myotonic Dystrophy Type 1 (DM1) Sales by Region: 2018-2034
3.2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region: 2018-2023
3.2.2 Global Myotonic Dystrophy Type 1 (DM1) Sales by Region: 2024-2034
3.3 Global Myotonic Dystrophy Type 1 (DM1) Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region: 2018-2034
3.3.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region: 2018-2023
3.3.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region: 2024-2034
3.4 North America Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
3.4.1 North America Myotonic Dystrophy Type 1 (DM1) Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2034)
3.4.3 North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
3.5.1 Europe Myotonic Dystrophy Type 1 (DM1) Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2034)
3.5.3 Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
3.6.1 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2034)
3.6.3 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
3.7.1 Latin America Myotonic Dystrophy Type 1 (DM1) Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2034)
3.7.3 Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
3.8.1 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2034)
3.8.3 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2018-2034)
4.1.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2018-2023)
4.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2024-2034)
4.1.3 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2018-2034)
4.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2018-2034)
4.2.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2018-2023)
4.2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2024-2034)
4.2.3 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2018-2034)
4.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2018-2034)
5 Segment by Application
5.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2018-2034)
5.1.1 Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2018-2023)
5.1.2 Global Myotonic Dystrophy Type 1 (DM1) Sales by Application (2024-2034)
5.1.3 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2018-2034)
5.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2018-2034)
5.2.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2018-2023)
5.2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2024-2034)
5.2.3 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2018-2034)
5.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Dyne
6.1.1 Dyne Corporation Information
6.1.2 Dyne Description and Business Overview
6.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.1.5 Dyne Recent Developments/Updates
6.2 Audentes
6.2.1 Audentes Corporation Information
6.2.2 Audentes Description and Business Overview
6.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.2.5 Audentes Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Vertex
6.4.1 Vertex Corporation Information
6.4.2 Vertex Description and Business Overview
6.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.4.5 Vertex Recent Developments/Updates
6.5 PepGen
6.5.1 PepGen Corporation Information
6.5.2 PepGen Description and Business Overview
6.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.5.5 PepGen Recent Developments/Updates
6.6 NeuBase Therapeutics
6.6.1 NeuBase Therapeutics Corporation Information
6.6.2 NeuBase Therapeutics Description and Business Overview
6.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.6.5 NeuBase Therapeutics Recent Developments/Updates
6.7 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lupin Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 AMO Pharma
6.8.1 AMO Pharma Corporation Information
6.8.2 AMO Pharma Description and Business Overview
6.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.8.5 AMO Pharma Recent Developments/Updates
6.9 Expansion Therapeutics
6.9.1 Expansion Therapeutics Corporation Information
6.9.2 Expansion Therapeutics Description and Business Overview
6.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.9.5 Expansion Therapeutics Recent Developments/Updates
6.10 Harmony Biosciences
6.10.1 Harmony Biosciences Corporation Information
6.10.2 Harmony Biosciences Description and Business Overview
6.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Portfolio
6.10.5 Harmony Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Myotonic Dystrophy Type 1 (DM1) Industry Chain Analysis
7.2 Myotonic Dystrophy Type 1 (DM1) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Myotonic Dystrophy Type 1 (DM1) Production Mode & Process
7.4 Myotonic Dystrophy Type 1 (DM1) Sales and Marketing
7.4.1 Myotonic Dystrophy Type 1 (DM1) Sales Channels
7.4.2 Myotonic Dystrophy Type 1 (DM1) Distributors
7.5 Myotonic Dystrophy Type 1 (DM1) Customers
8 Myotonic Dystrophy Type 1 (DM1) Market Dynamics
8.1 Myotonic Dystrophy Type 1 (DM1) Industry Trends
8.2 Myotonic Dystrophy Type 1 (DM1) Market Drivers
8.3 Myotonic Dystrophy Type 1 (DM1) Market Challenges
8.4 Myotonic Dystrophy Type 1 (DM1) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Myotonic Dystrophy Type 1 (DM1) Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Myotonic Dystrophy Type 1 (DM1) Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Myotonic Dystrophy Type 1 (DM1), Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Myotonic Dystrophy Type 1 (DM1), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Myotonic Dystrophy Type 1 (DM1), Product Type & Application
Table 12. Global Key Manufacturers of Myotonic Dystrophy Type 1 (DM1), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Myotonic Dystrophy Type 1 (DM1) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myotonic Dystrophy Type 1 (DM1) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2018-2023) & (Units)
Table 18. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2018-2023)
Table 19. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2024-2034) & (Units)
Table 20. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2024-2034)
Table 21. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2018-2023)
Table 23. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2024-2034)
Table 25. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2023) & (Units)
Table 27. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2024-2034) & (Units)
Table 28. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2023) & (Units)
Table 32. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2024-2034) & (Units)
Table 33. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2023) & (Units)
Table 42. Latin America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2024-2034) & (Units)
Table 43. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) by Type (2018-2023)
Table 51. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) by Type (2024-2034)
Table 52. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2018-2023)
Table 53. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2024-2034)
Table 54. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2018-2023)
Table 57. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2024-2034)
Table 58. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Type (2018-2023)
Table 59. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Type (2024-2034)
Table 60. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) by Application (2018-2023)
Table 61. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) by Application (2024-2034)
Table 62. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2018-2023)
Table 63. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2024-2034)
Table 64. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2018-2023)
Table 67. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2024-2034)
Table 68. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Application (2018-2023)
Table 69. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Application (2024-2034)
Table 70. Dyne Corporation Information
Table 71. Dyne Description and Business Overview
Table 72. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Dyne Myotonic Dystrophy Type 1 (DM1) Product
Table 74. Dyne Recent Developments/Updates
Table 75. Audentes Corporation Information
Table 76. Audentes Description and Business Overview
Table 77. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Audentes Myotonic Dystrophy Type 1 (DM1) Product
Table 79. Audentes Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Myotonic Dystrophy Type 1 (DM1) Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Vertex Corporation Information
Table 86. Vertex Description and Business Overview
Table 87. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Vertex Myotonic Dystrophy Type 1 (DM1) Product
Table 89. Vertex Recent Developments/Updates
Table 90. PepGen Corporation Information
Table 91. PepGen Description and Business Overview
Table 92. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. PepGen Myotonic Dystrophy Type 1 (DM1) Product
Table 94. PepGen Recent Developments/Updates
Table 95. NeuBase Therapeutics Corporation Information
Table 96. NeuBase Therapeutics Description and Business Overview
Table 97. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product
Table 99. NeuBase Therapeutics Recent Developments/Updates
Table 100. Lupin Corporation Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Lupin Myotonic Dystrophy Type 1 (DM1) Product
Table 104. Lupin Recent Developments/Updates
Table 105. AMO Pharma Corporation Information
Table 106. AMO Pharma Description and Business Overview
Table 107. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product
Table 109. AMO Pharma Recent Developments/Updates
Table 110. Expansion Therapeutics Corporation Information
Table 111. Expansion Therapeutics Description and Business Overview
Table 112. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product
Table 114. Expansion Therapeutics Recent Developments/Updates
Table 115. Harmony Biosciences Corporation Information
Table 116. Harmony Biosciences Description and Business Overview
Table 117. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product
Table 119. Harmony Biosciences Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Myotonic Dystrophy Type 1 (DM1) Distributors List
Table 123. Myotonic Dystrophy Type 1 (DM1) Customers List
Table 124. Myotonic Dystrophy Type 1 (DM1) Market Trends
Table 125. Myotonic Dystrophy Type 1 (DM1) Market Drivers
Table 126. Myotonic Dystrophy Type 1 (DM1) Market Challenges
Table 127. Myotonic Dystrophy Type 1 (DM1) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Myotonic Dystrophy Type 1 (DM1)
Figure 2. Global Myotonic Dystrophy Type 1 (DM1) Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Type in 2024 & 2034
Figure 4. Exondys Product Picture
Figure 5. Emflaza Product Picture
Figure 6. Translarna Product Picture
Figure 7. Global Myotonic Dystrophy Type 1 (DM1) Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application in 2024 & 2034
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Home Care
Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Myotonic Dystrophy Type 1 (DM1) Market Size (2018-2034) & (US$ Million)
Figure 14. Global Myotonic Dystrophy Type 1 (DM1) Sales (2018-2034) & (Units)
Figure 15. Global Myotonic Dystrophy Type 1 (DM1) Average Price (US$/Unit) & (2018-2034)
Figure 16. Myotonic Dystrophy Type 1 (DM1) Report Years Considered
Figure 17. Myotonic Dystrophy Type 1 (DM1) Sales Share by Manufacturers in 2024
Figure 18. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Myotonic Dystrophy Type 1 (DM1) Players: Market Share by Revenue in 2024
Figure 20. Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2018-2034)
Figure 23. North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2018-2034)
Figure 24. United States Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2018-2034)
Figure 27. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2018-2034)
Figure 28. Germany Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2018-2034)
Figure 35. China Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2018-2034)
Figure 45. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type (2018-2034)
Figure 55. Global Revenue Market Share of Myotonic Dystrophy Type 1 (DM1) by Type (2018-2034)
Figure 56. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Application (2018-2034)
Figure 58. Global Revenue Market Share of Myotonic Dystrophy Type 1 (DM1) by Application (2018-2034)
Figure 59. Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit) by Application (2018-2034)
Figure 60. Myotonic Dystrophy Type 1 (DM1) Value Chain
Figure 61. Myotonic Dystrophy Type 1 (DM1) Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed